Skip to content
Back to the Guavy Wire
Stocks

Analysts Divided on Healthcare Stocks Insulet, UnitedHealth, and Ottobock

Instruments
UNH
Share

Analysts have recently shared mixed opinions on several healthcare stocks, including Insulet (PODD), UnitedHealth (UNH), and Ottobock SE & Co. KGaA (OBCKF). Robert W. Baird analyst Jeff Johnson downgraded Insulet to Hold with a price target of $158.00, noting the stock closed last Thursday at $137.23. Johnson, a 5-star analyst with a 9.7% average return, covers healthcare stocks like Zimmer Biomet Holdings and Beta Bionics.

UnitedHealth received a Buy rating and a $455.00 price target from TD Cowen analyst Ryan Langston. The stock closed last Thursday at $330.48. Langston, a 3-star analyst with a 1.1% average return, focuses on healthcare stocks such as Alignment Healthcare and Acadia Healthcare. The consensus on UnitedHealth is a Strong Buy with an average price target of $486.00, suggesting a 38.4% upside.

Henrik Paganetty from Jefferies maintained a Buy rating on Ottobock SE & Co. KGaA with a price target of EUR83.00. The current analyst consensus for Ottobock is a Strong Buy, but the average price target of $73.69 indicates a -99.1% downside from current levels. Deutsche Bank also maintained a Buy rating with a EUR56.00 price target.

More on Stocks